keyword
https://read.qxmd.com/read/38635907/gut-dysbiosis-impairs-intestinal-renewal-and-lipid-absorption-in-scarb2-deficiency-associated-neurodegeneration
#1
JOURNAL ARTICLE
Yinghui Li, Xingchen Liu, Xue Sun, Hui Li, Shige Wang, Wotu Tian, Chen Xiang, Xuyuan Zhang, Jiajia Zheng, Haifang Wang, Liguo Zhang, Li Cao, Catherine C L Wong, Zhihua Liu
Scavenger receptor class B, member 2 (SCARB2) is linked to Gaucher disease (GD) and Parkinson's disease (PD). Deficiency in the SCARB2 gene causes progressive myoclonus epilepsy (PME), a rare group of inherited neurodegenerative diseases characterized by myoclonus. We found that Scarb2 deficiency in mice leads to age-dependent dietary lipid malabsorption, accompanied with vitamin E deficiency. Our investigation revealed that Scarb2 deficiency is associated with gut dysbiosis and an altered bile acid pool, leading to hyperactivation of FXR in intestine...
April 18, 2024: Protein & Cell
https://read.qxmd.com/read/38635098/multiple-gastric-neuroendocrine-tumors-in-a-patient-with-parietal-cell-dysfunction-and-adenosine-triphosphatase-h-k-transporting-subunit-alpha-gene-variant
#2
JOURNAL ARTICLE
Yu Sasaki, Yasuhiko Abe, Ken Haruma, Hidenori Sato, Makoto Yagi, Naoko Mizumoto, Yusuke Onozato, Minami Ito, Takahiro Watabe, Yoshiyuki Ueno
A 47-year-old woman presented with multiple gastric tumors, each up to 10 mm in diameter, in the gastric body and fundus without mucosal atrophy. White spots and numerous transparent, light-brownish, small, and rounded spots were observed in the background gastric mucosa. Biopsy specimens obtained from the tumors revealed gastric neuroendocrine tumors. The patient exhibited hypergastrinemia and achlorhydria and tested negative for serum parietal cell antibody, intrinsic factor antibody, and Helicobacter pylori infection...
April 18, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38633246/the-lack-of-ppar%C3%AE-exacerbated-the-progression-of-non-alcoholic-steatohepatitis-in-mice-with-spleen-deficiency-syndrome-by-triggering-an-inflammatory-response
#3
JOURNAL ARTICLE
Jiawen Huang, Jiayu Li, Yuan Peng, Tianqi Cui, Jingyi Guo, Siwei Duan, Kaili Zhou, Shangyi Huang, Jiabing Chen, Qincheng Yi, Min Qiu, Tingting Chen, Xiaoqin Wu, Chenlu Ma, Ziyi Zhang, Yi Zheng, Xi Tang, Yanqing Pang, Lei Zhang, Chong Zhong, Yong Gao
BACKGROUND: In addition to abnormal liver inflammation, the main symptoms of non-alcoholic steatohepatitis (NASH) are often accompanied by gastrointestinal digestive dysfunction, consistent with the concept of spleen deficiency (SD) in traditional Chinese medicine. As an important metabolic sensor, whether peroxisome proliferator-activated receptor alpha (PPARα) participates in regulating the occurrence and development of NASH with SD (NASH-SD) remains to be explored. METHODS: Clinical liver samples were collected for RNA-seq analysis...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38628626/effects-of-abrocitinib-on-pruritus-and-eczema-symptoms-and-tolerance-in-patients-with-moderate%C3%A2-to%C3%A2-severe-atopic-dermatitis-in-randomized-double%C3%A2-blind-and-placebo%C3%A2-controlled-trials-a-systematic-review-and-a-meta%C3%A2-analysis
#4
JOURNAL ARTICLE
Xingxing Xie, Jie Zhang, Fujing Huang, Ling Fan
Abrocitinib is a highly selective Janus kinase 1 (JAK1) inhibitor that can block a multitude of inflammatory signaling pathways that underlie atopic dermatitis (AD). In addition, abrocitinib inhibits JAK1 signaling in sensory neurons to alleviate acute and chronic pruritus during AD. However, substantial variations in efficacy and safety risks remain due to variations in doses applied in clinical use. Therefore for the present study, differences in the efficacy and tolerability of 100 and 200 mg abrocitinib for treating pruritus and eczema symptoms in patients with moderate-to-severe AD were evaluated compared with placebo...
May 2024: Biomedical Reports
https://read.qxmd.com/read/38625142/patients-with-autoimmune-liver-disease-have-glucose-disturbances-that-mechanistically-differ-from-steatotic-liver-disease
#5
JOURNAL ARTICLE
Anne-Sofie H Jensen, Henriette Ytting, Mikkel P Werge, Elias B Rashu, Liv E Hetland, Mira Thing, Puria Nabilou, Johan Burisch, Kirstine N Bojsen-Møller, Anders E Junker, Lise Hobolth, Christian Mortensen, Flemming Tofteng, Flemming Bendtsen, Søren Møller, Mogens Vyberg, Reza R Serizawa, Lise L Gluud, Nicolai J Wewer Albrechtsen
Autoimmune liver diseases are associated with an increased risk of diabetes, yet the underlying mechanisms remain unknown. In this cross-sectional study, we investigated the glucose-regulatory disturbances in patients with autoimmune hepatitis (AIH, n=19), primary biliary cholangitis (PBC, n=15), and primary sclerosing cholangitis (PSC, n=6). Healthy individuals (n=24) and patients with metabolic dysfunction-associated steatotic liver disease (MASLD, n=18) were included as controls. Blood samples were collected during a 120 min oral glucose tolerance test...
April 16, 2024: American Journal of Physiology. Gastrointestinal and Liver Physiology
https://read.qxmd.com/read/38623942/the-prevalence-and-predictors-of-metabolic-dysfunction-associated-steatotic-liver-disease-and-fibrosis-cirrhosis-among-adolescents-young-adults
#6
JOURNAL ARTICLE
Brandon J Perumpail, Richie Manikat, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed, Donghee Kim
OBJECTIVES: We investigated the current prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and fibrosis/cirrhosis and identified at-risk populations for MASLD and MASLD-related fibrosis among US adolescents and young adults in the United States. METHODS: Utilizing the National Health and Nutrition Examination Survey 2017-2020, the prevalence of MASLD and fibrosis/cirrhosis was assessed via controlled attenuation parameter (CAP) score and liver stiffness measurements by transient elastography in participants aged 12-29 years with at least one cardiometabolic criteria and absence of other chronic liver disease...
April 16, 2024: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/38623922/correlating-neighborhood-level-deprivation-and-pediatric-metabolic-dysfunction-associated-steatotic-liver-disease
#7
JOURNAL ARTICLE
Nicole E Hickman, Mason Price, Noe C Crespo, Ariel E Feldstein
OBJECTIVES: The primary objective of this study is to further explore associations between social influencers of health and markers of disease severity at the time of presentation of patients with pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) using neighborhood-level Area Deprivation Index (ADI) scores. METHODS: A retrospective cross-sectional study was conducted among 344 pediatric MASLD patients. Each patient received an ADI score based on their 9-digit zip code...
April 16, 2024: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/38621241/gastroenterology-hepatology-what-you-may-have-missed-in-2023
#8
JOURNAL ARTICLE
Sama Anvari, Kayla Dadgar, Ciarán Galts, Michael Bretthauer
This article summarizes clinically important gastroenterology developments from 2023 for internal medicine specialists. In colorectal cancer screening, a new RNA fecal screening test is on the horizon, as well as a new analysis on the benefits of using artificial intelligence in screening colonoscopy to detect more polyps. There is new evidence for management of gastrointestinal bleeding, a new drug for treatment of recurrent small-intestinal angiodysplasia, and a new endoscopic treatment method in patients with gastrointestinal tumor bleeding...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38617460/current-remarks-and-future-directions-on-the-interactions-between-metabolic-dysfunction-associated-fatty-liver-disease-and-covid-19
#9
EDITORIAL
Leonidas Brilakis, Eirini Theofilogiannakou, Panagis M Lykoudis
During the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, particular interest rose regarding the interaction between metabolic dysfunction-associated fatty liver disease (MAFLD) and the COVID-19 infection. Several studies highlighted the fact that individuals with MAFLD had higher probability of severe acute respiratory syndrome coronavirus 2 infection and more severe adverse clinical outcomes. One of the proposed mechanisms is the inflammatory response pathway, especially the one involving cytokines, such as interleukin 6, which appeared particularly elevated in those patients and was deemed responsible for additional insult to the already damaged liver...
March 21, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38617455/effects-of-lactobacillus-paracasei-n1115-on-gut-microbial-imbalance-and-liver-function-in-patients-with-hepatitis-b-related-cirrhosis
#10
RANDOMIZED CONTROLLED TRIAL
Yan-Chao Hu, Xiang-Chun Ding, Hui-Juan Liu, Wan-Long Ma, Xue-Yan Feng, Li-Na Ma
BACKGROUND: Hepatitis B cirrhosis (HBC) is a chronic disease characterized by irreversible diffuse liver damage and aggravated by intestinal microbial imbalance and metabolic dysfunction. Although the relationship between certain single probiotics and HBC has been explored, the impact of the complex ready-to-eat Lactobacillus paracasei N1115 (LP N1115) supplement on patients with HBC has not been determined. AIM: To compare the changes in the microbiota, inflammatory factor levels, and liver function before and after probiotic treatment in HBC patients...
March 21, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38615717/glucagon-based-therapy-for-people-with-diabetes-and-obesity-what-is-the-sweet-spot
#11
JOURNAL ARTICLE
Emma Rose McGlone, Tricia M-M Tan
People with obesity and type 2 diabetes have a high prevalence of metabolic-associated steatotic liver disease, hyperlipidemia and cardiovascular disease. Glucagon increases hepatic glucose production; it also decreases hepatic fat accumulation, improves lipidemia and increases energy expenditure. Pharmaceutical strategies to antagonize the glucagon receptor improve glycemic outcomes in people with diabetes and obesity, but they increase hepatic steatosis and worsen dyslipidemia. Co-agonism of the glucagon and glucagon-like peptide-1 (GLP-1) receptors has emerged as a promising strategy to improve glycemia in people with diabetes and obesity...
April 12, 2024: Peptides
https://read.qxmd.com/read/38615177/hemodynamics-and-arrhythmia-disorder-caused-by-lithium-poisoning-a-case-report
#12
JOURNAL ARTICLE
Yujue Wang, Lijun Ouyang, Xiaoqian Ma, Danyan Xu, Xiaogang Chen, Ying He
Bipolar affective disorder refers to a category of mood disorders characterized clinically by the presence of both manic or hypomanic episodes and depressive episodes. Lithium stands out as the primary pharmacological intervention for managing bipolar affective disorder. However, its therapeutic dosage closely approaches toxic levels. Toxic symptoms appear when the blood lithium concentration surpasses 1.4 mmol/L, typically giving rise to gastrointestinal and central nervous system reactions. Cardiac toxicity is rare but serious in cases of lithium poisoning...
January 28, 2024: Zhong Nan da Xue Xue Bao. Yi Xue Ban, Journal of Central South University. Medical Sciences
https://read.qxmd.com/read/38613690/dynamic-change-of-metabolic-dysfunction-associated-steatotic-liver-disease-in-patients-with-hepatitis-c-virus-infection-after-achieving-sustained-virologic-response-with-direct-acting-antivirals
#13
JOURNAL ARTICLE
Chen-Hua Liu, Yu-Ping Chang, Yu-Jen Fang, Pin-Nan Cheng, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin, Sheng-Shun Yang, Yu-Lueng Shih, Cheng-Yuan Peng, Ming-Chang Tsai, Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
BACKGROUND: Information on the dynamics of metabolic dysfunction-associated steatotic liver disease (MASLD) among hepatitis C virus patients achieving sustained virologic response (SVR12 ) with direct-acting antivirals (DAAs) is limited. METHODS: We enrolled 1512 eligible participants in this prospective study. MASLD was defined by a controlled attenuation parameter (CAP) of ≥248 dB/m utilizing vibration-controlled transient elastography in conjunction with presence of  ≥1 cardiometabolic risk factor...
April 13, 2024: Journal of Gastroenterology
https://read.qxmd.com/read/38610776/endoscopic-management-of-post-sleeve-gastrectomy-complications
#14
REVIEW
Muaaz Masood, Donald E Low, Shanley B Deal, Richard A Kozarek
Obesity is associated with several chronic conditions including diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease and malignancy. Bariatric surgery, most commonly Roux-en-Y gastric bypass and sleeve gastrectomy, is an effective treatment modality for obesity and can improve associated comorbidities. Over the last 20 years, there has been an increase in the rate of bariatric surgeries associated with the growing obesity epidemic. Sleeve gastrectomy is the most widely performed bariatric surgery currently, and while it serves as a durable option for some patients, it is important to note that several complications, including sleeve leak, stenosis, chronic fistula, gastrointestinal hemorrhage, and gastroesophageal reflux disease, may occur...
March 29, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38608741/early-treatment-with-rifaximin-during-epileptogenesis-reverses-gut-alterations-and-reduces-seizure-duration-in-a-mouse-model-of-acquired-epilepsy
#15
JOURNAL ARTICLE
Valentina Kebede, Teresa Ravizza, Silvia Balosso, Rossella Di Sapia, Luca Canali, Sara Soldi, Serena Galletti, Christina Papazlatani, Panagiotis A Karas, Sotirios Vasileiadis, Annalisa Sforzini, Laura Pasetto, Valentina Bonetto, Annamaria Vezzani, Loredana Vesci
The gut microbiota is altered in epilepsy and is emerging as a potential target for new therapies. We studied the effects of rifaximin, a gastrointestinal tract-specific antibiotic, on seizures and neuropathology and on alterations in the gut and its microbiota in a mouse model of temporal lobe epilepsy (TLE). Epilepsy was induced by intra-amygdala kainate injection causing status epilepticus (SE) in C57Bl6 adult male mice. Sham mice were injected with vehicle. Two cohorts of SE mice were fed a rifaximin-supplemented diet for 21 days, starting either at 24 h post-SE (early disease stage) or at day 51 post-SE (chronic disease stage)...
April 10, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38606856/acute-liver-failure-caused-by-high-dose-tigecycline-a-case-report
#16
JOURNAL ARTICLE
Yingpei Zhang, Jiajun Wang, Yibin Tan, Jianhua Wu
High-dose tigecycline is gradually being introduced for the treatment of serious infectious diseases due to the increasing difficulty in treating pan-resistant bacterial infections. However, the safety of high-dose tigecycline is controversial. We report the case of a 76-year-old female patient with cerebral hemorrhage who received high-dose tigecycline (100 mg q12h) with other drugs for ventilator-associated pneumonia. 25 days after admission, she developed acute liver failure, mainly manifested by abnormally high bilirubin, coagulation dysfunction, and gastrointestinal hemorrhage with hemorrhagic shock...
April 12, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38605969/the-gastrointestinal-microbiota-in-the-development-of-me-cfs-a-critical-view-and-potential-perspectives
#17
REVIEW
Andreas Stallmach, Stefanie Quickert, Christian Puta, Philipp A Reuken
Like other infections, a SARS-CoV-2 infection can also trigger Post-Acute Infection Syndromes (PAIS), which often progress into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). ME/CFS, characterized by post-exercise malaise (PEM), is a severe multisystemic disease for which specific diagnostic markers or therapeutic concepts have not been established. Despite numerous indications of post-infectious neurological, immunological, endocrinal, and metabolic deviations, the exact causes and pathophysiology remain unclear...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38605390/patient-reported-experience-with-fabry-disease-and-its-management-in-the-real-world-setting-results-from-a-double-blind-cross-sectional-survey-of-280-respondents
#18
JOURNAL ARTICLE
Lisa Berry, Jerry Walter, Jack Johnson, Julia Alton, Janet Powers, Xavier Llòria, Irene Koulinska, Meghan McGee, Dawn Laney
BACKGROUND: Fabry disease (FD) is a rare X-linked lysosomal storage disorder with a heterogeneous clinical presentation. Patients with FD may exhibit early signs/symptoms including neuropathic pain, gastrointestinal complaints, and dermatologic manifestations. FD may ultimately progress to renal, neurologic, and cardiac dysfunction. Current treatments for FD have significantly improved the management and outcomes for patients with FD, but important clinical and convenience limitations still exist...
April 11, 2024: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/38603861/minimally-invasive-vagus-nerve-stimulation-modulates-mast-cell-degranulation-via-the-microbiota-gut-brain-axis-to-ameliorate-blood-brain-barrier-and-intestinal-barrier-damage-following-ischemic-stroke
#19
JOURNAL ARTICLE
Yanan Wang, Qianqian Tan, Mingdong Pan, Jiaying Yu, Shaoqi Wu, Wenzhan Tu, Ming Li, Songhe Jiang
Mast cells (MCs) play a significant role in various diseases, and their activation and degranulation can trigger inflammatory responses and barrier damage. Several studies have indicated that vagus nerve stimulation (VNS) exerts ameliorates neurological injury, and regulates gut MC degranulation. However, there is limited research on the modulatory effect of VNS on MCs in both the gut and brain in brain ischemia-reperfusion (I/R) injury in this process. We aim to develop a minimally invasive, targeted and convenient VNS approach to assess the impact of VNS and to clarify the relationship between VNS and MCs on the prognosis of acute ischemic stroke...
April 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38602474/periodontitis-increases-the-risk-of-gastrointestinal-dysfunction-an-update-on-the-plausible-pathogenic-molecuar-mechanisms
#20
REVIEW
Sayantan Mukherjee, Aditi Chopra, Shaswata Karmakar, Subraya Giliyar Bhat
Periodontitis is an immuno-inflammatory disease of the soft tissues surrounding the teeth. Periodontitis is linked to many communicable and non-communicable diseases such as diabetes, cardiovascular disease, rheumatoid arthritis, and cancers. The oral-systemic link between periodontal disease and systemic diseases is attributed to the spread of inflammation, microbial products and microbes to distant organ systems. Oral bacteria reach the gut via swallowed saliva, whereby they induce gut dysbiosis and gastrointestinal dysfunctions...
April 11, 2024: Critical Reviews in Microbiology
keyword
keyword
118879
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.